Table 2. Donor lungs and EVLP characteristics between the control and PP group.
| Variable | Control (n=4) | PP (n=4) | P value |
|---|---|---|---|
| Donor age, years | 44.8±9.4 | 49.0±8.8 | 0.59 |
| Donor body weight, kg | 65.8±5.6 | 60.3±5.3 | 0.26 |
| Donor ventilation, days | 2.8±1.9 | 5.0±3.1 | 0.32 |
| Donor P/F, mmHg | 457.5±109.6 | 339±55.6 | 0.15 |
| Donor lung CIT, hours | 20.5±2.6 | 20.3±2.3 | 0.90 |
| Reason for rejection | |||
| Infection | 2 | 3 | |
| P/F <300 mmHg | 1 | 1 | |
| Localized lesion | 1 | 0 | |
| EVLP period, hours | 10.0±1.6 | 12.0±0 | 0.07 |
| Reason for early termination | |||
| Low PaO2 | 1 | 0 | |
| Edema | 2 | 0 |
Measurement data are expressed as mean ± SD. P/F, the partial pressure of O2 in arterial blood/fraction of inhaled oxygen; CIT, cold ischemia time. PP, perfusate purification; EVLP, ex vivo lung perfusion.